ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,795.65
1.44%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Dyadic International Inc (DYAI)

  7. Dyadic International Inc (DYAI) Noticias

DYAI Dyadic International Inc

1.43
-0.07 (-4.67%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dyadic International Inc DYAI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.07 -4.67% 1.43 15:05:32
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.48 1.40 1.4999 1.43 1.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:30GLOBEDyadic to Report First Quarter 2024 Financial Results on..
28/3/202415:00GLOBEDyadic Reports 2023 Full Year Results and Recent Company..
28/3/202407:30GLOBEDyadic Announces Change in Board and Management Leadership..
27/3/202407:30GLOBEDyadic to Attend Industry Events in April
26/3/202407:30GLOBEDyadic Announces Publication of C1 Monoclonal Antibody in..
21/3/202407:30GLOBEDyadic to Attend Future Food Tech Event March 21 – 22, 2024..
14/3/202415:30GLOBEDyadic to Report Full Year 2023 Financial Results and Host..
11/3/202408:57GLOBECORRECTION – Dyadic Announces Closing of Private Placement..
11/3/202407:45EDGAR2Form 8-K - Current report
11/3/202407:30GLOBEDyadic Announces Closing of Private Placement of $6.0..
01/3/202407:30GLOBEDyadic to Attend Industry Events in March
28/2/202407:30GLOBEDyadic Announces Strategic Partnership Agreement to..
21/2/202407:30GLOBEDyadic Advances Collaboration with Israel Institute for..
13/2/202415:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202407:30GLOBEDyadic and Cygnus Technologies Announce Partnership To..
06/2/202407:30GLOBEDyadic Announces Research and Development Collaboration..
01/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202407:30GLOBEDyadic to Attend BIO CEO & Investor Conference and European..
04/1/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202407:30GLOBEDyadic to Attend J.P. Morgan 42nd Annual Healthcare..
30/11/202307:30GLOBEDyadic Attends Investor Events in December
29/11/202307:30GLOBEDyadic Announces Top-Line Results from its Successful Phase..
20/11/202307:30GLOBEDyadic’s C1 Platform to be Used to Produce Vaccines..
08/11/202315:09EDGAR2Form 8-K - Current report
08/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:00GLOBEDyadic Announces Third Quarter 2023 Financial Results and..
30/10/202307:30GLOBEDyadic to Present at Industry Events in November
25/10/202315:30GLOBEDyadic to Report Third Quarter 2023 Financial Results on..
09/10/202307:30GLOBEDyadic Appoints Doug Pace to Its Executive Leadership Team
06/10/202315:20EDGAR2Form 8-K - Current report
06/10/202315:10EDGAR2Form 8-K - Current report
05/10/202307:30GLOBEDyadic’s C1 Platform Selected by the Vaccine and..
29/9/202307:30GLOBEDyadic to Present at Industry and Investor Events in October
26/9/202307:30GLOBEDyadic and bYoRNA Announce a Collaboration Targeting the..
19/9/202307:30EDGAR2Form 8-K - Current report
19/9/202307:00GLOBEDyadic Announces Development and License Agreement to..
12/9/202315:30GLOBEDyadic to Present at BioProcess International
27/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
09/8/202315:10EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202315:08EDGAR2Form 8-K - Current report
09/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
DYAI
Dyadic
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados